The Cancer Hormone Therapy Market was valued at US$ 26.61 Billion in 2024 and is projected to reach US$ 58.58 Billion by 2031, registering a CAGR of 11.93% during 2025–2031. This version emphasizes balanced demand, technology, competition, and execution. Decision-makers should connect market growth to verified customer needs, operating constraints, and measurable value. What is driving...